RxDoctor Payments Data

Kate Vasconcellos, MD

Colon & Rectal Surgery · Milwaukee, WINPI 1437477320

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 90.9% of it on its own, with 9 other manufacturers making up the rest.

$3,104in general payments, 2019–2025

Across 33 payments — averaging $94.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Baxter Healthcare$111
  • Ipsen Biopharmaceuticals, Inc$51
  • Conmed Corporation$33
  • Acell, Inc.$18
  • Takeda Pharmaceuticals U.S.A., Inc.$15
  • plus $53 from 4 others

What the payments were for

  • Travel & lodging$58919%
  • Food & beverage$1,49848%
  • Education$1,00032%
  • Gifts$161%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,104 in reported general payments places this provider in the 55th percentile of 27 colon & rectal surgery providers in Wisconsin.

See all colon & rectal surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$53,230
Medicare patients
98
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate36$205
Metronidazole39$78
Ondansetron Hcl27$66
Tramadol Hcl12$18

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →